29.80

2.63% -0.805

Biodesix Inc (BDSX)

Overview News Price History Option Chain Financials Discussions Forecast

Biodesix Inc stock is traded at $29.80, with a volume of 64,269. It is down -2.63% in the last 24 hours and up +34.09% over the past month. Biodesix Inc is a diagnostic solutions company with a focus on lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources: providing diagnostic testing services associated with blood-based lung and COVID tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties, as well as the development and commercialization of companion diagnostics.

Previous Close:

$30.60

Open:

$30.64

24h Volume:

64,269

Relative Volume:

0.78

Market Cap:

$314.37M

Revenue:

$96.10M

Net Income/Loss:

$-31.96M

P/E Ratio:

-7.3994

EPS:

-4.0267

Net Cash Flow:

$-25.27M

1W Performance:

+23.99%

1M Performance:

+34.09%

6M Performance:

+94.36%

1Y Performance:

+216.97%

1-Day Range:

$29.11

$31.06

1-Week Range:

$23.95

$31.31

52-Week Range:

$5.26

$31.31

Biodesix Inc Stock (BDSX) Company Profile

Name

Biodesix Inc

Sector

Healthcare (1088)

Industry

Diagnostics & Research (50)

Phone

303-417-0500

Address

919 WEST DILLON ROAD, LOUISVILLE

Employee

334

Twitter

Next Earnings Date

2026-08-05

Latest SEC Filings

BDSX's Discussions on Twitter

Compare BDSX vs TMO, DHR, NTRA, A, IQV

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
BDSX Biodesix Inc	29.80	253.54M	96.10M	-31.96M	-25.27M	-4.0267
TMO Thermo Fisher Scientific Inc	632.88	232.03B	45.20B	6.87B	6.75B	18.19
DHR Danaher Corp	216.93	151.78B	24.78B	3.68B	5.29B	5.1743
NTRA Natera Inc	338.01	46.82B	2.50B	-226.32M	71.51M	-1.6412
A Agilent Technologies Inc	157.61	44.14B	7.23B	1.41B	1.09B	4.979
IQV Iqvia Holdings Inc	263.92	42.15B	16.63B	1.39B	2.12B	8.0674

Biodesix Inc Stock (BDSX) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Feb-27-26	Upgrade	William Blair	Mkt Perform → Outperform
May-14-25	Downgrade	William Blair	Outperform → Mkt Perform
Sep-16-24	Initiated	Scotiabank	Sector Outperform
Jul-26-24	Initiated	Craig Hallum	Buy
May-13-24	Initiated	TD Cowen	Buy
May-03-24	Initiated	Lake Street	Buy
Nov-17-21	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Nov-23-20	Initiated	BTIG Research	Buy
Nov-23-20	Initiated	Canaccord Genuity	Buy
Nov-23-20	Initiated	Morgan Stanley	Overweight
Nov-23-20	Initiated	William Blair	Outperform

View All

Biodesix Inc Stock (BDSX) Latest News

Aug 20, 2026

Biodesix (BDSX) Q2 2026 Results: The Bottom-Line Figure Outpaces Its Comparison on the Day; After Earnings: The Stock Loses 5.91% in the Latest SessionCEO Earnings Statement - vinanet.vn

Aug 20, 2026

Aug 19, 2026

Biodesix (BDSX) Results Check: The Bottom-Line Figure Beats Its Comparison; After Earnings: The Market Price Declines 3.91% in Latest TradingGuidance Accuracy Score - Vinanet

Aug 19, 2026

Aug 18, 2026

46,989 Shares in Biodesix, Inc. $BDSX Purchased by GSA Capital Partners LLP - MarketBeat

Aug 18, 2026

Aug 17, 2026

AIGH Capital Management LLC Acquires New Stake in Biodesix, Inc. $BDSX - MarketBeat

Aug 17, 2026

Aug 15, 2026

Biodesix (BDSX) Edges Higher at $24.0 as Bulls Defend Key SupportVol Target Rebalance - vinanet.vn

Aug 15, 2026

Walleye Capital LLC Makes New $1.68 Million Investment in Biodesix, Inc. $BDSX - MarketBeat

Aug 15, 2026

Sei Investments Co. Makes New Investment in Biodesix, Inc. $BDSX - MarketBeat

Aug 15, 2026

Aug 14, 2026

Biodesix Stock Price Forecast. Should You Buy BDSX? - StockInvest.us

Aug 14, 2026

BDSX Q2 2026 Earnings: EPS Beats Estimates by 22.85% as Loss NarrowsEarnings Preview - vinanet.vn

Aug 14, 2026

Aug 13, 2026

Biodesix director Jack Schuler buys company stock, valued at $366,991 By Investing.com - Investing.com Australia

Aug 13, 2026

Biodesix director Jack Schuler buys company stock, valued at $366,991 - Investing.com

Aug 13, 2026

BDSX Q2 2026 Earnings: Narrower Loss Beats Estimates as Shares Dip 1.78Earnings Yield Spread - Vinanet

Aug 13, 2026

Biodesix (NASDAQ:BDSX) Director Jack Schuler Buys 15,000 Shares of Stock - MarketBeat

Aug 13, 2026

Biodesix Insider Bought Shares Worth $366,992, According to a Recent SEC Filing - marketscreener.com

Aug 13, 2026